Biotech

All Articles

Vertex, beaten by AATD once again, drops 2 assets on dispose of pile

.Tip's effort to deal with an uncommon genetic illness has actually struck one more misfortune. The ...

Vir gains 3 T-cell engagers coming from Sanofi, lays off 25% of personnel

.Vir Medical's second-quarter profits record wasn't short of big news. The provider welcomed a trio ...

Galapagos pauses CAR-T cell treatment litigation over Parkinsonism case

.Galapagos has actually stopped briefly registration in a test of a BCMA-directed CAR-T tissue treat...

James Wilson leaving Penn to launch pair of brand new biotechs

.After much more than thirty years, gene therapy innovator James Wilson M.D., Ph.D., is leaving behi...

3 biotechs try to trump the summer season heat energy through dropping staff

.As biotechs attempt to switch a new webpage in August, a minimum of three companies have dropped wo...

venBio raises $528M for 5th lifestyle scientific researches VC fund

.Pro equity capital firm venBio has raised yet another half a billion dollars to buy biotechs workin...

Otsuka pays for $800M for Jnana as well as its own clinical-stage PKU drug

.Otsuka Drug has gotten Boston-based Jnana Therapeutics for $800 thousand so the Eastern biotech can...

FibroGen gives up 75% people staff as asset fails 2 even more trials

.FibroGen is drastically restructuring its business, giving up 75% of its U.S. workers and also ceas...

Tracon wane weeks after injectable PD-L1 prevention fall short

.Tracon Pharmaceuticals has actually decided to wind down functions full weeks after an injectable i...

Ideaya bags possibility on Biocytogen bispecific ADC in $400M bargain

.Ideaya Biosciences is actually betting $400 million in biobucks that a bispecific antibody-drug con...